Comprehensive Treatment of Angina in Women With Microvascular Dysfunction
Status:
Completed
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
Angina is the most common symptom of coronary heart disease among women but unlike men most
women do not have stenosis of the coronary arteries. In a large proportion of these women,
coronary microvascular dysfunction (CMD) is thought to be the cause of angina. However, CMD
is also demonstrable in the asymptomatic population, and may merely be an innocent bystander
related to the presence of cardiovascular risk factors rather than a cause of angina
symptoms.
The aim of this study is to determine whether comprehensive intervention is feasible and
results in improvement in both angina and microvascular function in these patients.
Phase:
N/A
Details
Lead Sponsor:
Bispebjerg Hospital
Collaborators:
Cambridge Weight Plan Limited University Hospital Bispebjerg and Frederiksberg